Orakl Oncology
PrivateLast Round
Seed
Dec 3, 2024
Total Funding Raised
$14.7M
Momentum
Top 1%
of companies Caplight tracks
Company Overview
Orakl Oncology is a biotechnology company that develops an AI-driven platform using patient-derived tumor avatars to accelerate cancer drug discovery and development.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Subscription SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Orakl Oncology Comparables
Compare Orakl Oncology with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| TwinEdge Bioscience | 83% | |
| DeepLife | 83% | |
| QuantHealth | 82% |
Orakl Oncology Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Dec 3, 2024 | ||||
| Pre Seed | Oct 4, 2023 |
Orakl Oncology Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Verve Ventures | Seed, Pre Seed |
| Singular | Seed |
| Speedinvest | Seed, Pre Seed |
| HCVC | Seed, Pre Seed |
| Bpifrance | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 1, 2026
Grew 19% QoQ, from 32 to 38 employees.
- Aug 20, 2026
Monthly visitors grew 160% MoM, reaching 3.3K.
Orakl Oncology Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Orakl Oncology's valuation, stock price, and market status.
Is Orakl Oncology a public or private company?
Orakl Oncology is a private company.
What is the current stock price of Orakl Oncology?
Orakl Oncology is a private company with no public stock price. No recent secondary market data is available.
How much is Orakl Oncology worth (valuation)?
Valuation information for Orakl Oncology is not publicly available.
Can I buy Orakl Oncology stock?
Orakl Oncology shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Orakl Oncology's last funding round?
Orakl Oncology's most recent funding round was Seed on December 3, 2024.
Who are the main investors in Orakl Oncology?
Key investors in Orakl Oncology include Singular, Speedinvest.
Will Orakl Oncology IPO soon?
No public IPO plans have been announced for Orakl Oncology.
How can I track Orakl Oncology secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Orakl Oncology's secondary market activity and sign up for updates.